Yourgene Health Plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VILGF research report →
About the company
Yourgene Health Plc is a molecular diagnostics firm specializing in the development, manufacturing, and commercialization of advanced genomic solutions, primarily for prenatal screening and diverse other applications across the UK, Europe, and globally. The company's in-vitro diagnostic (IVD) portfolio features key products such as the IONA Test, a non-invasive prenatal test (NIPT) for screening pregnant women for Down's, Edwards', and Patau's syndromes. Other diagnostics include Cystic Fibrosis Screening tests, Rapid Aneuploidy Analysis (a confirmatory diagnostic performed post-amniocentesis), and a Recurrent Pregnancy Loss PCR assay that identifies the six most common chromosomes linked to miscarriage.
- CEO
- Lyn Dafydd Rees
- IPO
- 2013
- Employees
- 253
- HQ
- Manchester, GB
Price Chart
- Market Cap
- $20.67M
- P/E
- -1.97
- P/S
- 0.44
- P/B
- 0.11
- EV/EBITDA
- 14.28
- Div Yield
- 0.00%
- Gross Margin
- 56.88%
- Op Margin
- -6.76%
- Net Margin
- -5.10%
- ROE
- -5.84%
- ROIC
- -2.76%
- 52W High
- $0.14
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.05
- Beta
- 0.86
- Avg Volume
- 708
Get TickerSpark's AI analysis on VILGF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VILGF coverage
Recent articles, reports, and earnings notes.
No research on VILGF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VILGF report →Similar companies
Peers in the same neighborhood.